Funding Opportunities
Funding Opportunities

Since 1981, AFAR has provided more than $181 million to nearly 4,200 talented investigators and students. To learn more about each grant, click below or contact the AFAR grant program staff at

Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research

(Formerly called the Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging)

This program was developed to address the current concerns about an adequate funding base for postdoctoral fellows (MD, MD/PhD and PhD) who specifically direct their research towards basic aging mechanisms and/or translational findings that have direct benefits to human aging. Postdoctoral fellows at all levels of training are eligible. Up to ten one-year fellowships of $60,000 will be awarded in 2019. 

Please note: The 2019 awards are closed and Letters of Intent are no longer being accepted. Please check back in Fall 2019 for updated materials.


The Program

The Glenn Foundation for Medical Research, in partnership with the American Federation for Aging Research (AFAR), created the Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research to encourage and further the careers of postdoctoral fellows, who are conducting research in the basic biology of aging, as well as translating advances in basic research from the laboratory to the clinic. The award is intended to provide significant research and training support to permit these postdoctoral fellows to become established in the field of aging.

The Glenn Foundation Postdoctoral Fellowship program supports research projects concerned with understanding the basic mechanisms of aging as well as projects that have direct relevance to human aging if they show the potential to lead to clinically-relevant strategies that address human aging and healthspan. Projects investigating age-related diseases will be considered, if approached from the point of view of how basic aging processes may lead to these outcomes. Projects concerning mechanisms underlying common geriatric functional disorders such as frailty will also be considered. Projects that are strictly clinical in nature such as the diagnosis and treatment of disease, health outcomes, or the social context of aging are not eligible.

It is anticipated that up to 10 one-year grants will be awarded in 2019. The grant is $60,000, of which $52,000 (*see note below) is to be used for salary and the remainder to be used for allowable expenses (research supplies, equipment, health insurance, travel to scientific meetings where the Fellow is presenting his/her biology of aging research, and relevant research and educational training). (* The applicant’s salary/stipend must equal or exceed NIH pay scales for postdoctoral fellowships, appropriate to the level of training. Thus, if the NIH stipend guidelines for the corresponding level of experience exceed $52,000, additional award funds may be taken as salary to meet the NIH standard.)
Recipients of this award are expected to attend the AFAR Grantee Conference; funds will be withheld from the grant for this purpose. The goal of the meeting is to promote scientific and personal exchanges among recent AFAR grantees and experts in aging research.


Eligibility Criteria


  • The applicant must be a postdoctoral fellow (MD and/or PhD degree or equivalent) at the start date of the award (July 1, 2019).
  • The proposed research must be conducted at a qualified not-for-profit setting in the United States.
  • Individuals who are employees in the NIH Intramural program are not eligible.
  • Individuals who are currently receiving financial support at a Paul F. Glenn Center for Biology of Aging Research are not eligible.
  • Applicants whose total postdoctoral training period is greater than 5 years (began postdoctoral training before July 1, 2014) must provide a justification for the additional training period.
  • Fellows may not hold any concurrent not-for-profit or government funding for the same research project.

Former Glenn postdoctoral fellowship awardees may apply if the criteria above are met. Applicants who submitted an LOI to the Diamond/AFAR postdoctoral award may also apply for the Glenn postdoctoral fellowship but can only accept one if recommended for both awards.

Applications from underrepresented groups in the biomedical sciences are encouraged.

Application Guidelines

The following criteria are used to determine the merit of an application:

  • Qualifications of the applicant
  • Quality of the proposed research
  • Proposed career development plan, and training opportunities for the applicant
  • Excellence of the research environment
  • Likelihood that the project will advance the applicant's career in aging research
  • Mentor's strength and qualifications to guide the applicant's research and career planning

If you are using animals in your research, please review Principles of Animal Use for Gerontological Research.

Application Procedures

The deadline for receipt of all Letters of Intent is January 22, 2019 at 5:00 p.m. EST. Please refer to the Glenn Letter of Intent. Incomplete or late submissions will not be considered. All Letters of Intent must be emailed to The Letters of Intent will be reviewed by a committee. Applicants will be notified by late March 2019, and a subset of applicants will be invited to submit a full application by mid May 2019. Final awards are announced by July 2019 and the award start date is July 1, 2019. AFAR will not provide reviewer critiques to any applicants at any review level.
For Glenn Letter of Intent, click here.
Click here for our Frequently Asked Questions page.

Reporting Requirements

Investigators will be required to submit narrative and financial reports within three months following the end date of the award.

Glenn Foundation for Medical Research

Founded by Paul F. Glenn in 1965, the mission of the Glenn Foundation For Medical Research is to extend the healthy years of life through research on mechanisms of biology that govern normal human aging and its related physiological decline, with the objective of translating research into interventions that will extend healthspan with lifespan.